Onchocerciasis in Anambra State, Southeast Nigeria: Clinical and psychological aspects and sustainability of community directed treatment with ivermectin (CDTI)

Postgraduate Medical Journal

Volumn 86, Issue 1020, 2010, Pages 573-577

  Mbanefo, Evaristus C ^a   Eneanya, Christine I ^a   Nwaorgu, Obioma C ^a   Oguoma, Victor M ^a   Otiji, Moses O ^b   Ogolo, Bernice A ^a  

^a NNAMDI AZIKIWE UNIVERSITY   (Nigeria)

^b Ministry of Health   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN; ANTIFILARIAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL EXAMINATION; COMMUNITY CARE; CROSS-SECTIONAL STUDY; DRUG COST; FEMALE; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL PAIN; NIGERIA; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PSYCHOLOGICAL ASPECT; RESTLESSNESS; SELF ESTEEM; SKIN MANIFESTATION; SOCIAL ISOLATION; ATTITUDE TO HEALTH; FEAR; MIDDLE AGED; PERCEPTION; PRURITUS; RURAL HEALTH CARE; SELF CONCEPT; SOCIAL PSYCHOLOGY;

ADULT; ATTITUDE TO HEALTH; COMMUNITY HEALTH SERVICES; CROSS-SECTIONAL STUDIES; FEAR; FEMALE; FILARICIDES; HUMANS; IVERMECTIN; MALE; MIDDLE AGED; NIGERIA; ONCHOCERCIASIS; PERCEPTION; PRURITUS; RURAL HEALTH SERVICES; SELF CONCEPT; STEREOTYPING;

EID: 78049491317     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/pgmj.2010.100248     Document Type: Article

References (28)

1. World Health Organization. The Importance of Onchocercal Skin Diseases. Document TDR/ONCHO/95.1 1995.
2. World Health Organization. Expert Committee on the Epidemiology of Onchocerciasis. WHO Technical Report Series No. 597 1976.
3. World Health Organization/African Programme for Onchocerciasis Control. Community Directed Treatment with Ivermectin: Sustainability and Ownership. http://www.who.int/blindness/partnerships/APOC/en/ (accessed May 2009).
4. Dozie INS, Onwuliri COE, Nwoke BEB, et al. Onchocerciasis in Imo State, Nigeria 1: the prevalence and distribution in the Imo River Basin, Nigeria. Nig J Parasitol 2006;27:16-22.
5. Okoye IC, Onwulili COE. Epidemiology and psycho-social aspects of onchocercal skin diseases in northeastern Nigeria. Filaria J 2007;6:15.
6. Amazigo UO. Detrimental Effects of Onchocerciasis on marriage and breast-feeding. Trop Geogr Med 1994;46:322-5.
7. Eneanya CI, Nwaorgu OC. Social and Psychological Aspects of Onchocercal Skin Disease in Nkwelle-Ezunaka, Anambra State. Nigeria. Nig J Parasitol 2001;22:11-16.
8. Vlassoff C, Weiss M, Ovuga EB, et al. Gender and the stigma of onchocercal skin disease in Africa. Soc Sci Med 2000;50:1353-68. (Pubitemid 30100384)
9. Okeibunor JC, Ogungbemi MK, Sama M, et al. Additional health and development activities for community-directed distributors of ivermectin: Threat or opportunity for onchocerciasis control? Trop Med Int Health 2004;9:887d-96d.
10. Remme JHF. Research for control: The onchocerciasis experience. Trop Med Int Health. 2004;9:243-54.
11. Hall L, Pearlman E. Pathogenesis of Onchocercal Keratitis. Clin Microbiol Rev 1999;12:445-53.
12. Benton B. Economic impact of onchocerciasis control: an overview. Ann Trop Med Parasitol 1998;92:33-9.
13. Amazigo U, Okeibunor J, Matovu V, et al. Performance of predictors: Evaluating sustainability in community-directed treatment projects of the African programme for onchocerciasis control. Soc Sci Med 2007;64:2070-82. (Pubitemid 46582824)
14. Hopkins AD. Onchocerciasis control: impressive achievements not to be wasted. Canadian J Ophthalmol 2007;42:13-15.
15. Ngoumou P, Walsh JP. Manual for Rapid Epidemiological Mapping of Onchocerciasis. UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases and WHO Programme for the Prevention of Blindness 1993;37.TDR/TDE/ONCHO/93.4.
16. WHO/APOC. Community Directed Treatment with Ivermectin (CDTI). A Practical Guide for Trainers of Community Directed Distributors 1998. Ouagadougou Burkina Faso.
17. Noma M, Nwoke BE, Nutall I, et al. Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol 2002;96:29-39.
18. Nwoke BEB, Dozie INS, Gemade EII, et al. The Present Status of Onchocerciasis in southern Nigeria using Rapid Epidemiological Mapping of Onchocerciasis (REMO). Nig J Parasitol 1998;19:11-18.
19. Murdoch ME, Hay RJ, Mackenzie CD, et al. A Clinical Classification and Grading System of the Cutaneous changes in Onchocerciasis. Br J Dermatol 1993;129:260-9.
20. Winnen M, Plaisier AP, Alley ES, et al. Can ivermectin mass treatments eliminate onchocerciasis in Africa? Bulletin of the World Health Organization 2002;80:384-91.
21. Ubachukwu PO. Human Onchocerciasis: Epidemiological Status of Uzo Uwani L.G.A. of Enugu State. Nig J Parasitol 2004;25:93-9.
22. Okolo CG, Dallah CN, Okonkwo PO. Clinical Manifestations of Onchocerciasis and some aspects of its Control in Achi, oji River L.G.A., Enugu State. Nig J Parasitol 2004;25:101-6.
23. Anosike JC, Onwuliri COE, Onwuliri VA. The prevalence, intensity and clinical manifestations of Onchocerca volvulus infection in Toro L.G.A. of Bauchi State, Nigeria. Int J Environ Health. 2001;203:459-64.
24. Duke BOL, Anderson J. Comparison Of the lesions produced in the cornea of the rabbit Eye by microfilariae of the Forest and Sudan Savanna strains of Onchocerca volvulus from, Cameroon. I. The clinical picture. Ztschr. Tropenmed. Parasit 1972:354.
25. Amazigo UO, Obikeze DS. Socio-cultural factors associated with prevalence and intensity of onchocerciasis and onchodermatitis among adolescent girls in rural Nigeria. Unpublished WHO/TDR ® final project report 1991.
26. Brieger WR, Ramakrishna J, Adeniyi JD, et al. Onchocerciasis and pregnancy. Trop Doctor 1987;17:17.
27. Nwoke BEB. The socio-economic aspects of human onchocerciasis in Africa: present appraisal. J Hyg Epidemiol Microbiol Immunol 1990;34:37.
28. Amazigo U. The African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol 2008;102(Suppl 1):19-22.